CAD and neoplasm: While E-Cadherin is a defined tumor suppressor that is inactivated by transcriptional or promoter methylation mechanisms [69], the shed soluble ectodomain (sE-Cad) exhibits oncogenic activity [61] and its levels increased in RUNX2+ cells.